CoChat

Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis

Open access
Nayak, Smita, Greenspan, Susan L. · 2017 · Journal of the American Geriatrics Society
Cited by 79

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objectives: To evaluate the efficacy of treatment options to reduce osteoporotic fracture risk in men. Design: Systematic review and meta‐analysis. Setting: Randomized clinical trials that evaluated the efficacy of a treatment for osteoporosis or low bone mineral density for adult men and reported fracture outcomes. Participants: Men. Measurements: PubMed, Embase, and the Cochrane Library databases were searched for relevant studies. Information was extracted from included studies on participant sociodemographic characteristics, number of male participants, treatment evaluated, comparator for evaluated treatment, study duration, and fracture outcomes. Risk of bias of individual studies was assessed using measures recommended by the Cochrane Collaboration. Results: Twenty‐four articles reporting results for 22 studies (including 4,868 male participants) met strict inclusion criteria. Fixed‐effects meta‐analyses using the Mantel‐Haenszel method demonstrated significantly lower risk of vertebral fractures with alendronate (relative risk ( RR ) = 0.328, 95% confidence interval ( CI ) = 0.155–0.692) and risedronate ( RR = 0.428, 95% CI = 0.245–0.746) but not with calcitonin ( RR = 0.272, 95% CI = 0.046–1.608) or denosumab ( RR = 0.256, 95% CI = 0.029–2.238) than in controls. For bisphosphonates as a treatment category, meta‐analyses demonstrated significantly lower risk of vertebral fractures ( RR = 0.368, 95% CI = 0.252–0.537) and nonvertebral fractures ( RR = 0.604, 95% CI = 0.404–0.904) than in controls. The meta‐analysis finding that bisphosphonates significantly reduce nonvertebral fracture risk was not robust to sensitivity analysis. Conclusion: Bisphosphonates reduce the risk of vertebral and possibly nonvertebral fractures for men with osteoporosis. Further studies are needed to evaluate the efficacy of bisphosphonates for reducing nonvertebral fracture risk and the efficacy of nonbisphosphonates for reducing vertebral and nonvertebral fracture risk in men with osteoporosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgs.14668

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 79

Metadata

Authors
Nayak, S., & Greenspan, S. L.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2016-11-07
Volume
65
Issue
3
Pages
490-495
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W2552495159
Cited by
79
References
6
FWCI
0.88
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.